Korean J Intern Med.  2025 Mar;40(2):243-250. 10.3904/kjim.2024.181.

Characteristics and outcomes of portal vein thrombosis in patients with inflammatory bowel disease in Korea

• Kim KJ
• Song SB
• Park JB
• Bae JH
• Baek JE
• Kim GH
• Kim MJ
• Hong SW
• Hwang SW
• Yang DH
• Ye BD
• Byeon JS
• Myung SJ
• Yang SK
• Yu CS
• Yoon YS
• Lee JL
• Kim MH
• Lee HS
• Park SH

• KMID: 2567101
• DOI: http://doi.org/10.3904/kjim.2024.181

Abstract

Background/Aims
Portal vein thrombosis (PVT) frequently occurs in patients with inflammatory bowel disease (IBD), particularly when influenced by factors such as abdominal infections, IBD flare-ups, or surgical procedures. The implications of PVT range from immediate issues such as intestinal ischemia to long-term concerns including portal hypertension and its complications. However, there is a notable gap in comprehensive studies on PVT in IBD, especially with the increasing incidence of IBD in Asia. This research aimed to evaluate the clinical features and outcomes of PVT in patients with IBD at a leading hospital in South Korea.
Methods
This retrospective analysis reviewed adult patients diagnosed with both IBD and PVT from 1989 to 2021 at a renowned South Korean medical center. The study focused on patient characteristics, specifics of PVT, administered treatments, and outcomes, all confirmed through enhanced CT scans.
Results
A total of 78 patients met the study’s criteria. Notably, only 20.5% (16/78) were treated with oral anticoagulants; however, a vast majority (96.2%; 75/78) achieved complete radiographic resolution (CRR). When comparing patients receiving anticoagulants to those who did not, a significant preference for anticoagulant use was observed in cases where the main portal vein was affected, as opposed to just the left or right veins (p = 0.006). However, multivariable analysis indicated that neither anticoagulant use nor previous surgeries significantly impacted CRR.
Conclusions
Patients with IBD and PVT generally had favorable outcomes, regardless of anticoagulant use.

Keyword

Inflammatory bowel disease; Venous thrombosis; Diagnostic imaging; Anticoagulation